1. Home
  2. ABP vs RMCO Comparison

ABP vs RMCO Comparison

Compare ABP & RMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABP
  • RMCO
  • Stock Information
  • Founded
  • ABP 2004
  • RMCO 2021
  • Country
  • ABP United States
  • RMCO United States
  • Employees
  • ABP N/A
  • RMCO N/A
  • Industry
  • ABP Biotechnology: Pharmaceutical Preparations
  • RMCO Multi-Sector Companies
  • Sector
  • ABP Health Care
  • RMCO Miscellaneous
  • Exchange
  • ABP Nasdaq
  • RMCO Nasdaq
  • Market Cap
  • ABP 15.5M
  • RMCO 14.9M
  • IPO Year
  • ABP N/A
  • RMCO N/A
  • Fundamental
  • Price
  • ABP $0.21
  • RMCO $1.05
  • Analyst Decision
  • ABP Strong Buy
  • RMCO
  • Analyst Count
  • ABP 1
  • RMCO 0
  • Target Price
  • ABP $4.00
  • RMCO N/A
  • AVG Volume (30 Days)
  • ABP 28.3M
  • RMCO 26.1K
  • Earning Date
  • ABP 05-15-2025
  • RMCO 05-15-2025
  • Dividend Yield
  • ABP N/A
  • RMCO N/A
  • EPS Growth
  • ABP N/A
  • RMCO N/A
  • EPS
  • ABP N/A
  • RMCO N/A
  • Revenue
  • ABP $183,000.00
  • RMCO $1,568,212.00
  • Revenue This Year
  • ABP N/A
  • RMCO N/A
  • Revenue Next Year
  • ABP N/A
  • RMCO N/A
  • P/E Ratio
  • ABP N/A
  • RMCO N/A
  • Revenue Growth
  • ABP 88.66
  • RMCO 204.08
  • 52 Week Low
  • ABP $0.15
  • RMCO $0.74
  • 52 Week High
  • ABP $11.19
  • RMCO $1.40
  • Technical
  • Relative Strength Index (RSI)
  • ABP N/A
  • RMCO 42.13
  • Support Level
  • ABP N/A
  • RMCO $1.03
  • Resistance Level
  • ABP N/A
  • RMCO $1.13
  • Average True Range (ATR)
  • ABP 0.00
  • RMCO 0.09
  • MACD
  • ABP 0.00
  • RMCO -0.01
  • Stochastic Oscillator
  • ABP 0.00
  • RMCO 22.84

About ABP Abpro Holdings Inc Common Stock

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

About RMCO Royalty Management Holding Corporation

Royalty Management Holding Corp formed to invest or purchase assets that have current or near-term income to provide the company with accretive cash flow from which it can reinvest in new assets or expand cash flow from existing assets. These assets typically are natural resources assets (including real estate and mining permits), patents, intellectual property, and emerging technologies.

Share on Social Networks: